The same substances that can alter perception and shift moods are now drawing scientific interest for their potential therapeutic abilities. Researchers across the globe are investigating whether psychedelics, such as psilocybin from magic mushrooms or LSD, could help treat mental health and brain-related disorders. In a recent study, researchers gathered many such studies and carried out a systematic review and meta-analysis focusing on the anti-inflammatory and immune-modulating properties of serotonergic psychedelics.
Exploring the Therapeutic Potential of Psychedelics for Immune System Disorders
Researchers are exploring the therapeutic potential of psychedelics like psilocybin and LSD for treating mental health and immune system disorders. This meta-analysis highlights the anti-inflammatory properties of these substances, which could have implications for healthcare approaches in Iran. The findings may influence how mental health issues are addressed in the country.
👥 Key Players
📰 What Happened
Researchers are investigating the therapeutic potential of psychedelics like psilocybin and LSD for treating mental health and immune system disorders. A recent systematic review highlights their anti-inflammatory properties.
- Psychedelics are being studied for their potential to treat both mental health and immune system disorders.
- The systematic review indicates that these substances may have anti-inflammatory effects.
💡 Why It Matters
📚 Background
Psychedelics have historically been associated with recreational use but are now being researched for their potential medical benefits, particularly in mental health.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%